Navigation Links
Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer
Date:5/28/2009

WAYNE, N.J., EMERYVILLE, Calif. and MELVILLE, N.Y., May 28 /PRNewswire-FirstCall/ -- Bayer HealthCare LLC., Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX), OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) and Roche today announced the initiation of a Phase 3 trial examining Nexavar(R) (sorafenib) tablets in combination with Tarceva(R) (erlotinib) tablets as a potential new treatment option for patients with advanced hepatocellular carcinoma (HCC), or primary liver cancer.

The SEARCH (Sorafenib and erlotinib, a randomized trial protocol for the treatment of patients with hepatocellular carcinoma) trial aims to further build on data from the Phase 3 SHARP trial, which demonstrated that Nexavar significantly extended overall survival in patients with unresectable liver cancer by 44 percent (HR=0.69; p-value=0.0006). Based on the strength of these data, Nexavar was approved for the treatment of patients with unresectable HCC in the United States and in Europe for the treatment of HCC. Nexavar is currently approved in more than 70 countries for the treatment of HCC, including China where more than half of all liver cancer cases worldwide occur each year.

"Nexavar is the only approved targeted therapy with efficacy and tolerability in liver cancer," said Dimitris Voliotis, MD, vice president, Nexavar Clinical Development, Bayer HealthCare Pharmaceuticals. "We look forward to seeing the potential of combining Nexavar with another effective cancer treatment, Tarceva, in treating this disease and further extending the lives of patients."

"This study will enable us to learn whether combining two oral targeted therapies, Nexavar and Tarceva, can improve survival in a disease that is difficult to trea
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.; OSI Pharmaceuticals; Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinsons Disease
2. The National Association of Boards of Pharmacy (NABP) Moves to Next Phase of Technician Recognition and Regulation
3. MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
4. Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well
5. National Medical Interpreter Certification Testing Enters Pilot Phase
6. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
7. Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting
8. Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Sarcoma and Osteosarcoma: Phase I/II and Phase II Studies, ASCO 2009
9. InDex Pharmaceuticals AB Engages PharmaVentures to Facilitate the Licensing of Kappaproct(R) After Phase IIa Trial Achieves Clinical Endpoints Early
10. BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting
11. Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Successful Development of NittoPhase™ HL High Loading Solid Support for Oligonucleotide Synthesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... The Northeast Football Clinic (NEFC) has trained ... school in Byfield, MA. Applications are being accepted for ... grades 6-12. , The outstanding professional, college, and high ... , Offensive and defensive linemen and linebackers ... most unsung positions on the field, the the success ...
(Date:4/21/2015)... 2015 Freeslate, Inc ., the ... today announced that the Centre for Catalysis Research ... has acquired a Freeslate Core Module 3 (CM3) ... (SPR) to accelerate current research programs. The systems ... they will be available to academic users and industrial ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 This ... pathologists, physical therapist assistants, occupational therapist assistants, teachers, ... and techniques to help children across the autism ... through Education Resources Inc. , ... 2008, this highly acclaimed yoga curriculum addresses learning ...
(Date:4/20/2015)... Draft, Virginia (PRWEB) April 20, 2015 ... Augusta Health facility in Stuarts Draft, an independent, ... County, Staunton, and Waynesboro, Virginia. The project was ... Architects. The Stuarts Draft facility is expected to ... , Located on Stuarts Draft Highway, the new ...
(Date:4/20/2015)... April 21, 2015 The National ... Binau, Founder of Soul Care Group, Inc., as ... is recognized with this prestigious distinction for leadership in ... Local Chapters, NAPW is the nation's leading networking organizaiton ... Susan with our Woman of the Year Award,” says ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3Health News:ABC News Interviews Anne Buckley-Reen, Education Resources Inc. Faculty Member, on Yoga Therapy in the Classroom 2Health News:Augusta Health Construction Wraps Up at Stuarts Draft 2Health News:National Association of Professional Women Announces Susan Binau, Founder of Soul Care Group, Inc., a 2015 Professional Woman of the Year 2
... Stabilized ... ENADH NADH, ... and distributor of nadh branded nutritional products, has,obtained the exclusive distribution ... the USA. ENADA,NADH was the original nadh product, stabilized by Prof. ...
... Breathing,Resistance Exerciser has been selected as the ... L.A. Times. Jorge Brouwer, inventor of the ... the easy,to use "Expand-A-Lung.", *(PHOTO ... Resistance Exerciser.) When asked about how ...
... Life Sciences,Inc. (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical ... vaccine at the 6th Congress of Medical Microbiology ... presentation was made by Dr. Dragan,Rogan, Vice-President, Bioniche ... vaccine is the world,s first vaccine that may ...
... June 17 For women about to give,birth, one ... ensuring they have on,hand the right music., (Photo: ... studies have found that music can reduce,anxiety and stress ... "There,s a lot of pain and discomfort that can ...
... Research in the United States has shown that obese people ... for breast, colon and cervical cancer. Raj Padwal, Rebecca Mitchell ... Medicine & Dentistry, have undertaken a study to see if ... obesity is associated with higher rates of some types of ...
... ,lack of motivation, ,lack of money, and ,lack of time, as, ... ... health, SANTA MONICA, Calif., June 17 Findings from a ... to improve their overall health, but less than half of those ...
Cached Medicine News:Health News:ENADA NADH Is Back 2Health News:Have You Exercised Your Lungs Today? 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia 3Health News:Using Music to Ease the Pain of Labor; New CD Featuring Celine Dion, Norah Jones, Provides Soothing Songs for Delivery 2Health News:Obese women in Canada are less likely to be screened for cervical cancer 2Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 2Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 3Health News:LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful 4
(Date:4/20/2015)... , April 20, 2015 Stand Up To Cancer ... of a $20 million Dream Team to attack the number ... the Annual Meeting of the American Association for Cancer Research ... that 221,000 people in the United States ... 2015, and 158,040 will die from it, making lung cancer ...
(Date:4/20/2015)... 20, 2015 Kalorama Information says that ... to be robust; the market is driven by ... global markets, new product innovations and increasing life ... market inhibitors, such as government restraints, limited hospital ... The healthcare market research publisher,s report, Insulin ...
(Date:4/20/2015)... INDIANAPOLIS , April 20, 2015 Eli ... that the investigational medicine ixekizumab was statistically superior to ... arthritis (PsA), as demonstrated by the proportion of patients ... standard assessment that represents a 20 percent reduction in ... College of Rheumatology response criteria. During the 24-week, Phase ...
Breaking Medicine Technology:New SU2C-American Cancer Society Lung Cancer Dream Team Announced 2New SU2C-American Cancer Society Lung Cancer Dream Team Announced 3New SU2C-American Cancer Society Lung Cancer Dream Team Announced 4New SU2C-American Cancer Society Lung Cancer Dream Team Announced 5New SU2C-American Cancer Society Lung Cancer Dream Team Announced 6Kalorama: Insulin Pump Market Growing Robustly 2Kalorama: Insulin Pump Market Growing Robustly 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 2Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 4
... 7 With the growth in the home health care ... Entertainment 2009® that it is offering OnCare by Xora, an ... helps address the specific needs of mobile health care workers ... , Designed specifically for use by home caregivers who travel ...
... Oct. 7 Odyssey Thera, Inc. announced that it ... Pfizer Inc. following Pfizer,s decision to progress drug candidates ... alliance with Pfizer announced in August, 2006. These milestones ... for the advancement of specific drug candidates, and follow ...
Cached Medicine Technology:Verizon Wireless Offers Home Health Care Industry Custom Mobile Application To Be More Productive 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: